Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma

被引:259
作者
Carey, Christopher D. [1 ,2 ]
Gusenleitner, Daniel [3 ]
Lipschitz, Mikel [3 ]
Roemer, Margaretha G. M. [4 ,5 ]
Stack, Edward C. [6 ]
Gjini, Evisa [3 ]
Hu, Xihao [7 ]
Redd, Robert [7 ]
Freeman, Gordon J. [3 ,4 ]
Neuberg, Donna [7 ]
Hodi, F. Stephen [3 ,4 ]
Liu, Xiaole Shirley [7 ]
Shipp, Margaret A. [3 ,4 ]
Rodig, Scott J. [1 ,3 ]
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02215 USA
[2] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England
[3] Dana Farber Canc Inst, Ctr Immunooncol, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[5] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands
[6] PerkinElmer Inc, Hopkinton, MA USA
[7] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
BRENTUXIMAB VEDOTIN; SUPPRESSOR-CELLS; T-CELLS; CLASS-I; PD-1; EXPRESSION; PEMBROLIZUMAB; AMPLIFICATION; ANTIBODIES; MOLECULES;
D O I
10.1182/blood-2017-03-770719
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Signaling between programmed cell death protein 1 (PD-1) and the PD-1 ligands (PD-L1, PD-L2) is essential for malignant Hodgkin Reed-Sternberg (HRS) cells to evade antitumor immunity in classical Hodgkin lymphoma (cHL). Copy number alterations of 9p24.1/CD274(PD-L1)/PDCD1LG2(PD-L2) contribute to robust PD-L1 and PD-L2 expression by HRS cells. PD-L1 is also expressed by nonmalignant tumor-associated macrophages (TAMs), but the relationships among PD-L1(+) HRS cells, PD-L1(+) TAMs, and PD-1(+) T cells remain undefined. We used multiplex immunofluorescence and digital image analysis to examine the topography of PD-L1(+) and PD-1(+) cells in the tumor microenvironment (TME) of cHL. We find that the majority of PD-L1 in the TME is expressed by the abundant PD-L1(+) TAMs, which physically colocalize with PD-L1(+) HRS cells in a microenvironmental niche. PD-L1(+) TAMs are enriched for contacts with T cells, and PD-L1(+) HRS cells are enriched for contacts with CD4(+) T cells, a subset of which are PD-1(+). Our data define a unique topology of cHL in which PD-L1(+) TAMs surround HRS cells and implicate CD4(+) T cells as a target of PD-1 blockade.
引用
收藏
页码:2420 / 2430
页数:11
相关论文
共 35 条
  • [31] Efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating non-Hodgkin lymphoma: A systematic review and meta-analysis of clinical trials
    Guan, Jiaheng
    Zhang, Jing
    Zhang, Xiaoping
    Yuan, Zhongshu
    Cheng, Jian
    Chen, Baoan
    MEDICINE, 2022, 101 (50)
  • [32] Enhanced PD-L1 expression on tumor cells in primary cutaneous large T-cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases
    Takahashi, Emiko
    Tsuchida, Takashi
    Baba, Satoshi
    Tsuzuki, Toyonori
    Shimauchi, Takatoshi
    Tokura, Yoshiki
    Tamada, Yasuhiko
    Nakamura, Shigeo
    PATHOLOGY INTERNATIONAL, 2020, 70 (10) : 804 - 811
  • [33] CD68-positive tumour associated macrophages, PD-L1 expression, and EBV latent infection in a high HIV-prevalent South African cohort of Hodgkin lymphoma patients
    Antel, Katherine
    Chetty, D.
    Oosthuizen, J.
    Mohamed, Z.
    van der Vyver, L.
    Verburgh, E.
    PATHOLOGY, 2021, 53 (05) : 628 - 634
  • [34] Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells
    Ishikawa, Eri
    Kato, Seiichi
    Shimada, Kazuyuki
    Tanaka, Tsutomu
    Suzuki, Yuka
    Satou, Akira
    Kohno, Kei
    Sakakibara, Ayako
    Yamamura, Takeshi
    Nakamura, Masanao
    Miyahara, Ryoji
    Goto, Hidemi
    Nakamura, Shigeo
    Hirooka, Yoshiki
    CANCER MEDICINE, 2018, 7 (12): : 6051 - 6063
  • [35] Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients
    Parra, Edwin R.
    Behrens, Carmen
    Rodriguez-Canales, Jaime
    Lin, Heather
    Mino, Barbara
    Blando, Jorge
    Zhang, Jianjun
    Gibbons, Don L.
    Heymach, John V.
    Sepesi, Boris
    Swisher, Stephen G.
    Weissferdt, Annikka
    Kalhor, Neda
    Izzo, Julie
    Kadara, Humam
    Moran, Cesar
    Lee, Jack J.
    Wistuba, Ignacio I.
    CLINICAL CANCER RESEARCH, 2016, 22 (24) : 6278 - 6289